An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination

Immunological adjuvants are essential for successful cancer vaccination. However, traditional adjuvants have some limitations, such as lack of controllability and induction of systemic toxicity, which restrict their broad application. Here, we present a light-activable immunological adjuvant (LIA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongchao, Gong, Ningqiang, Ma, Chi, Zhang, Yuxuan, Tan, Hong, Qing, Guangchao, Zhang, Jimei, Wang, Yufei, Wang, Jinjin, Chen, Shizhu, Li, Xianlei, Ni, Qiankun, Yuan, Yuan, Gan, Yaling, Chen, Junge, Li, Fangzhou, Zhang, Jinchao, Ou, Caiwen, Zhao, Yongxiang, Liu, Xiaoxuan, Liang, Xing-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368031/
https://www.ncbi.nlm.nih.gov/pubmed/34400628
http://dx.doi.org/10.1038/s41467-021-25197-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368031/
https://www.ncbi.nlm.nih.gov/pubmed/34400628
http://dx.doi.org/10.1038/s41467-021-25197-z

Ejemplares similares